Acute lymphoblastic leukemia (ALL) is the most frequent cancer in children. Despite
remarkable improvement in the prognosis of childhood ALL over the past few decades, the …

Background: Acute lymphoblastic leukemia (ALL) represents the most common malignancy
in children with an overall cure rate of 85%. Relapses occur in 20% of the cases. Commonly …

Acute lymphoblastic leukemia (ALL) is one of the most frequent hematological malignancies
in children, representing approximately 25% of all pediatric cancers. Despite striking …

Purpose The number of young cancer survivors has increased over the past few decades
due to improvement in treatment regimens, and understanding of long-term effects among …

Although we previously reported that the self-renewal of leukemia-initiating cells of B-
lineage acute lymphoblastic leukemia (B-ALL LICs) was regulated by β-Arrestin1, a multiple …

Background: As the number of cancer survivors increases, their health and welfare have
come into focus. Thus, long-term medical consequences of cancer at a young age (< 25 …

In this work we propose a bone metastasis model using power law growth functions in order
to describe the biochemical interactions between bone cells and cancer cells. Experimental …

This chapter explores the diverse scope of occupational therapy (OT) interventions in cancer
rehabilitation and addresses the unique challenges individuals face from childhood through …

Despite a high cure rate in childhood BCP-ALL, 20% of children still presents with relapse,
mostly due to a persistent leukemic clone during the first-line treatment. In this context …

This chapter focuses on the introduction to biologics and biosimilars, clinical application,
and biomarker testing. First, the concept of biologics and biosimilars is discussed and the …